News for 'diagnostics'

Labs say capping RT-PCR rates is big blow to business

Labs say capping RT-PCR rates is big blow to business

Rediff.com3 Apr 2021

'We urge the government to have discussions with private labs on the actual cost of running a test.'

Markets: 'Volatility to remain higher than usual'

Markets: 'Volatility to remain higher than usual'

Rediff.com3 Jun 2022

'Periods of high volatility are usually bad for mid-caps and this is something that has to be kept in mind.' 'Focus on quality is of paramount importance.'

In-principle nod for 6 nuclear power reactors at Jaitapur

In-principle nod for 6 nuclear power reactors at Jaitapur

Rediff.com16 Dec 2021

In-principle approval has been accorded to a site in Maharashtra's Jaitapur for setting up six nuclear power reactors of 1,650 MW each in technical cooperation with France, the government said on Thursday.

New low-cost test can diagnose COVID-19 in just 20 minutes

New low-cost test can diagnose COVID-19 in just 20 minutes

Rediff.com14 Aug 2020

The rapid molecular test is highly accurate and easy to use, making it a prime candidate for use in settings with limited testing capabilities, according to the researchers.

It's Raining Hollywood Biggies On OTT!

It's Raining Hollywood Biggies On OTT!

Rediff.com7 Mar 2022

Featuring 007 among others.

Private insurers want standard rates for treatment

Private insurers want standard rates for treatment

Rediff.com6 Apr 2020

Cost of the diagnostic test for Covid-19 has been fixed at Rs 4,500 per test by the government. Hospitals, however, do not think this is feasible.

India ends Covid curbs from March 31; face mask, social distancing to continue

India ends Covid curbs from March 31; face mask, social distancing to continue

Rediff.com23 Mar 2022

In view of the continuous dip in coronavirus cases, the home ministry has decided to end its all Covid-19 containment measures from March 31, two years after their implementation following the outbreak of the pandemic.

Despite cap on pricing import of medical devices rises

Despite cap on pricing import of medical devices rises

Rediff.com24 Jun 2019

The growth in imports was led by product categories such as diagnostic items, ultra-sonogram machines, MRI and ECG apparatus, syringes with needles, suture needles, digital thermometers, malaria diagnostic kits, and hearing aids.

Not yet clear if Omicron more transmissible: WHO

Not yet clear if Omicron more transmissible: WHO

Rediff.com29 Nov 2021

The World Health Organisation has said it is 'not yet clear' whether the newly-detected coronavirus variant Omicron is more transmissible or causes more severe disease compared to other variants, including the highly-transmissible and globally prevalent Delta variant.

How can you catch monkeypox? Govt lists dos and don'ts

How can you catch monkeypox? Govt lists dos and don'ts

Rediff.com3 Aug 2022

It underlined that anyone can catch the virus if they have had prolonged or repeated contact with an infected individual.

Record 9.18 lakh COVID tests done in a day in India

Record 9.18 lakh COVID tests done in a day in India

Rediff.com20 Aug 2020

The cumulative tests conducted so far for detection of coronavirus infection in the country has increased to 3,26,61,252.

ICMR removes price cap of Rs 4,500 for COVID-19 tests

ICMR removes price cap of Rs 4,500 for COVID-19 tests

Rediff.com26 May 2020

In a letter to the state chief secretaries on Monday, ICMR Director General (D-G) Dr Balram Bhargava said the COVID-19 diagnostic supplies are stabilising because of the indigenous production of the kits.

Mutual vaccine recognition eases international travel: Modi

Mutual vaccine recognition eases international travel: Modi

Rediff.com23 Sep 2021

Prime Minister Narendra Modi said on Wednesday that international travel should be made easier through mutual recognition of vaccine certificates, amid several countries adopting different sets of rules to allow foreigners to enter their territory in the wake of the COVID-19 pandemic.

Tata Trusts, private firm join hands to roll out coronavirus testing kits

Tata Trusts, private firm join hands to roll out coronavirus testing kits

Rediff.com8 Apr 2020

The test - called the Truenat Beta CoV test - effectively enables same-day testing, reporting, and patient isolation initiation.

Covid-19 pandemic: PEs pour $584 million into healthcare in 2021

Covid-19 pandemic: PEs pour $584 million into healthcare in 2021

Rediff.com11 Jun 2021

Sensing a huge opportunity in the healthcare sector during the Covid-19 pandemic and its aftermath, private equity (PE) players are upping their investments in the space. According to data from research platform VCCEdge, the PEs have together invested a staggering $583.82 million in the first five months of 2021 in five deals, which is the highest investment in the sector in the last five calendar years - from 2016 to 2020. The second highest investment in the sector took place in 2017, when PEs invested $503 million in 18 deals, with an average deal size of $29. 9 million.

Omicron: Airports ready to implement new health norms

Omicron: Airports ready to implement new health norms

Rediff.com30 Nov 2021

Under the new norms, passengers coming from 12 'at risk' countries/regions undergo an RT-PCR test and wait for result at the airport before leaving or taking a connecting flight

Ban on private labs in Mumbai may hit COVID-19 battle

Ban on private labs in Mumbai may hit COVID-19 battle

Rediff.com13 Jun 2020

The testing rate is likely to slow down, report Pavan Lall and Sohini Das.

Covaxin emergency use decision likely in 4-6 weeks: WHO

Covaxin emergency use decision likely in 4-6 weeks: WHO

Rediff.com10 Jul 2021

There is a process to be followed for EUL and pre-qualification of vaccines under which a company has to complete phase 3 trials and submit the whole data to the regulatory department of WHO which is examined by an expert advisory group," Swaminathan said.

Visit A Doc Frequently? Opt For OPD Cover

Visit A Doc Frequently? Opt For OPD Cover

Rediff.com19 Apr 2022

Most traditional health insurance plans didn't cover the cost of such treatments earlier, but several recently launched policies do offer such coverage -- some as a rider, and a few as standalone covers, points out Sarbajeet K Sen.

Tata Motors launches Nexon EV MAX at Rs 17.74 lakh

Tata Motors launches Nexon EV MAX at Rs 17.74 lakh

Rediff.com11 May 2022

Tata Motors on Wednesday expanded its electric vehicle range in the country with the launch of Nexon EV MAX, priced between Rs 17.74-19.24 lakh (ex-showroom). Equipped with a 40.5 kWh lithium-ion battery pack, the Nexon EV Max offers 33 per cent higher battery capacity than the Nexon EV, delivering ARAI certified range of 437 km (under standard testing conditions), ensuring uninterrupted inter-city travel. ARAI refers to Automotive Research Association of India. The model produces 105 kW (143 PS) of power and delivers a torque of 250 Nm, resulting in 0 to 100 sprint times in under 9 seconds.

Omicron: 'Vaccine immunity may be less effective'

Omicron: 'Vaccine immunity may be less effective'

Rediff.com7 Dec 2021

'Antiviral treatment will have no change. Spike protein change may affect the immunity protection.'

Unfazed by legal blocks, Netmeds bets big on digital

Unfazed by legal blocks, Netmeds bets big on digital

Rediff.com8 Feb 2019

Netmeds is looking at using new technologies such as deep learning and data analytics to improve forecasting in terms of the demand of the products for pharma companies, reports Peerzada Abrar.

US allows 'game-changer' saliva-based Covid test

US allows 'game-changer' saliva-based Covid test

Rediff.com16 Aug 2020

The new test it will enable rapid testing amongst more people easily.

MF GURU: 'High risk appetite. Where to invest?'

MF GURU: 'High risk appetite. Where to invest?'

Rediff.com10 Oct 2022

Nikunj Saraf, Vice President Choice Wealth, will answers your queries.

India to share Co-WIN source software with over 50 countries: R S Sharma

India to share Co-WIN source software with over 50 countries: R S Sharma

Rediff.com28 Jun 2021

About 50 countries, including Canada, Mexico, Nigeria and Panama, have shown interest in having a Co-WIN like system to run their vaccination drive, a senior official said on Monday, adding India is ready to share the open source software free of cost.

India's COVID-19 recovery rate rises to 68.32%

India's COVID-19 recovery rate rises to 68.32%

Rediff.com8 Aug 2020

India has one of the lowest cases per million at 1,469 as against the global average of 2,425, the government said.

G20 leaders vow to vaccinate 70% world population by mid-2022

G20 leaders vow to vaccinate 70% world population by mid-2022

Rediff.com31 Oct 2021

In the Rome Declaration, the G20 leaders thanked healthcare and frontline workers, international organisations and scientists for their relentless efforts to cope with the deadly COVID-19 pandemic.

Rs 40,000 cr approved to deal with Covid: Govt to LS

Rs 40,000 cr approved to deal with Covid: Govt to LS

Rediff.com20 Jul 2021

Rai said as informed by the health ministry, the central government has been providing required technical and financial assistance to all states and Union Territories (UTs) for strengthening their healthcare system, including management of the COVID-19 public health challenge, from time to time, and the financial assistance to states and UTs is provided under the National Health Mission (NHM).

This super app will offer a range of multi-brand services for passenger cars

This super app will offer a range of multi-brand services for passenger cars

Rediff.com18 Jul 2022

A single application and a plethora of services for passenger cars - that is what myTVS, a brand that operates under Ki Mobility Solutions and is part of the TVS family, is set to bring to customers, in a bid to disrupt the concept of "super apps" in India. Starting July 15, myTVS will launch its connected car platform or super app called myTVS Life360 for aftermarket passenger cars. Through it, customers will be able to avail themselves of a range of services like maintenance, diagnostics, roadside assistance, accessories, payments, insurance, and so on.

Stool sampling among Covid-19 test options before govt

Stool sampling among Covid-19 test options before govt

Rediff.com18 Apr 2020

Private diagnostic laboratories have already approached the respective state governments and the municipalities where they are operating to approve protocols for such testing in clusters, reports Sohini Das.

IIT-Delhi launches coronavirus kit, claimed to be world's most affordable

IIT-Delhi launches coronavirus kit, claimed to be world's most affordable

Rediff.com15 Jul 2020

The Corosure Kit has received ICMR approval with the highest score and DCGI approved with a very high sensitivity and specificity.

How India's healthcare system will change forever

How India's healthcare system will change forever

Rediff.com27 Aug 2020

The National Digital Health Mission seeks to provide a unique health ID to each citizen who wishes to have one and also on-board the healthcare service provides - hospitals, pharmacies and diagnostic labs, among others. It will have an online database of doctors and personal health records.

Have you had your blood tested yet?

Have you had your blood tested yet?

Rediff.com30 Jul 2018

Blood tests are a significant diagnostic method for disease detection, says Prashant Shetty.

Found: Doctor-medical centre nexus and Rs 100cr black money

Found: Doctor-medical centre nexus and Rs 100cr black money

Rediff.com2 Dec 2017

It claimed doctors were being paid 'for referring medical tests'.

Self-use Covid-19 testing kits to be available at stores for Rs 250

Self-use Covid-19 testing kits to be available at stores for Rs 250

Rediff.com21 May 2021

Pune's Mylab Discovery Solutions' CoviSelf, which gives results in 15 minutes, gets ICMR nod

Sayre Therapeutics: In the business of cancer

Sayre Therapeutics: In the business of cancer

Rediff.com21 Sep 2017

Sayre Therapeutics aims for a spot among top 5 players in oncology.

5 Tech Trends To Watch Out For

5 Tech Trends To Watch Out For

Rediff.com5 Jan 2022

Humans will work far more collaboratively with artificial intelligence for rapid and complex decision-making.

COVID-19 test method developed by IIT Delhi gets ICMR nod

COVID-19 test method developed by IIT Delhi gets ICMR nod

Rediff.com23 Apr 2020

IIT Delhi is the first academic institute to have obtained the ICMR approval for a real-time PCR- based diagnostic assay. The development also comes against the backdrop of the Indian Council of Medical Research halting the testing for COVID-19 cases through China-made test kits because of massive variation in test results, compounding the challenge to check and contain the pandemic.

'No preparedness planning, no accountability, no action plan'

'No preparedness planning, no accountability, no action plan'

Rediff.com8 May 2021

'This government did not have any plan for safety stocks of essential medicines.'

Reliance proposes using tapeworm drug to treat Covid patients

Reliance proposes using tapeworm drug to treat Covid patients

Rediff.com3 Jun 2021

Niclosamide, a drug on the World Health Organisation's list of essential medicines, has been used to treat tapeworm infestation for more than 50 years. The oral antiviral drug was also used to treat patients during the SARS outbreak of 2003-04.